CVRX INC. - COMMON STOCK

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

12 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire

CVRx Announces Appointment of Two New Board Members

03 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

CVRx Announces Increased Inpatient Payment for Barostim Procedure

02 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

31 июл 2024 15:27:00 Источник Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2024 Financial and Operating Results

29 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

15 июл 2024 15:30:00 Источник Nasdaq GlobeNewswire

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

25 июн 2024 05:50:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

22 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

CVRx Announces Key Senior Leadership Team Hires

16 май 2024 06:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports First Quarter 2024 Financial and Operating Results

30 апр 2024 15:05:00 Источник Nasdaq GlobeNewswire

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

16 апр 2024 15:30:00 Источник Nasdaq GlobeNewswire

CVRx announces availability of additional data supporting long-term benefits of Barostim

15 апр 2024 06:30:00 Источник Nasdaq GlobeNewswire

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

31 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

25 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

11 янв 2024 15:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

08 янв 2024 07:30:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 дек 2023 15:30:00 Источник Nasdaq GlobeNewswire

CVRx receives FDA approval for expanded labeling of Barostim

26 дек 2023 07:05:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

15 ноя 2023 15:21:43 Источник Nasdaq GlobeNewswire

CMS Increases Outpatient Payment for Barostim Procedure

03 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire